SKY classic 3.5 narrow platform: new tissue level solution for limited space

Increased biological width for stable soft tissue conditions and long-term aesthetic results

With the new SKY classic 3.5 narrow platform, bredent medical is expanding its SKY classic portfolio with a slimmer tissue-level solution for complex anatomical situations. The new platform variant supplements the existing range and replaces the previous SKY classic 3.5 implants with regular platform. It is specifically designed for narrow tooth gaps, reduced mesio-distal space and aesthetically challenging restorations. The increase in the biological distance from the adjacent teeth and implants creates the optimal conditions for a stable soft tissue environment and long-term aesthetic results.

Designed for complex anatomical situations
The SKY classic 3.5 narrow platform combines a reduced implant diameter with high implant-positioning flexibility. This makes it ideal for anterior and premolar restorations, situations in which there is a narrow gap to the adjacent teeth or implants, and for anatomically challenging indications such as thin, soft tissue biotypes or sloping alveolar ridges.

Tissue-level design supports biological stability
A key feature of the implant is its tissue-level design. The implant-abutment junction is located in the soft tissue outside the crestal bone area. This can reduce critical micro movements in the bone, promote soft tissue integration and preserve the crestal bone structure in the long term. At the same time, the design helps to reduce the risk of biological complications.
The implant is positioned 1 to 2 mm subgingivally, which creates the biologically necessary space for a stable papillae, bone and soft tissue environment. The tried and tested osseo-connect-surface (ocs)® also supports rapid osseointegration and hard and soft tissue integration.

Expansion of the SKY classic portfolio with seamless integration into existing workflows
With the SKY classic 3.5 narrow platform, bredent medical is adding a solution to its implant system for indications with limited space and high aesthetic requirements. The implant combines a reduced diameter with biological stability, thus expanding the therapeutic options available in cases with limited space.
In addition to the biological advantages, users benefit from full compatibility with the existing SKY prosthetics. This enables the new implant to be integrated into existing treatment and ordering processes without any adjustments.